Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/35774
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | de Viron, Sylviane | - |
dc.contributor.author | Trotta, Laura | - |
dc.contributor.author | Schumacher, Helmut | - |
dc.contributor.author | Lomp, Hans-Juergen | - |
dc.contributor.author | Hoppner, Sebastiaan | - |
dc.contributor.author | Young, Steve | - |
dc.contributor.author | BUYSE, Marc | - |
dc.date.accessioned | 2021-11-05T11:57:02Z | - |
dc.date.available | 2021-11-05T11:57:02Z | - |
dc.date.issued | 2022 | - |
dc.date.submitted | 2021-10-28T13:07:48Z | - |
dc.identifier.citation | Therapeutic innovation & regulatory science | - |
dc.identifier.uri | http://hdl.handle.net/1942/35774 | - |
dc.description.abstract | Background A central statistical assessment of the quality of data collected in clinical trials can improve the quality and efficiency of sponsor oversight of clinical investigations. Material and Methods The database of a large randomized clinical trial with known fraud was reanalyzed with a view to identifying, using only statistical monitoring techniques, the center where fraud had been confirmed. The analysis was conducted with an unsupervised statistical monitoring software using mixed-effects statistical models. The statistical analyst was unaware of the location, nature, and extent of the fraud. Results Five centers were detected as atypical, including the center with known fraud (which was ranked 2). An incremental analysis showed that the center with known fraud could have been detected after only 25% of its data had been reported. Conclusion An unsupervised approach to central monitoring, using mixed-effects statistical models, is effective at detecting centers with fraud or other data anomalies in clinical trials. | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER HEIDELBERG | - |
dc.rights | This article is licensed under a Creative Commons Attribution 4.0 International License, | - |
dc.subject.other | Statistical monitoring; Central monitoring; Risk-based monitoring; | - |
dc.subject.other | Fraud; Misconduct | - |
dc.title | Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 136 | - |
dc.identifier.spage | 130 | - |
dc.identifier.volume | 56 | - |
local.format.pages | 7 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | De Viron, S (corresponding author), CluePoints SA, Ave Albert Einstein,2a, B-1348 Louvain La Neuve, Belgium. | - |
dc.description.notes | sylviane.deviron@CluePoints.com | - |
local.publisher.place | TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.identifier.doi | 10.1007/s43441-021-00341-5 | - |
dc.identifier.isi | WOS:000701359000001 | - |
local.provider.type | wosris | - |
local.uhasselt.uhpub | yes | - |
local.description.affiliation | [de Viron, Sylviane; Trotta, Laura; Hoppner, Sebastiaan; Buyse, Marc] CluePoints SA, Ave Albert Einstein,2a, B-1348 Louvain La Neuve, Belgium. | - |
local.description.affiliation | [Lomp, Hans-Juergen] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany. | - |
local.description.affiliation | [Young, Steve] CluePoints Inc, King Of Prussia, PA USA. | - |
local.description.affiliation | [Buyse, Marc] Int Drug Dev Inst IDDI, Louvain La Neuve, Belgium. | - |
local.description.affiliation | [Buyse, Marc] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Hasselt, Belgium. | - |
local.uhasselt.international | yes | - |
item.fulltext | With Fulltext | - |
item.contributor | de Viron, Sylviane | - |
item.contributor | Trotta, Laura | - |
item.contributor | Schumacher, Helmut | - |
item.contributor | Lomp, Hans-Juergen | - |
item.contributor | Hoppner, Sebastiaan | - |
item.contributor | Young, Steve | - |
item.contributor | BUYSE, Marc | - |
item.accessRights | Open Access | - |
item.validation | ecoom 2023 | - |
item.fullcitation | de Viron, Sylviane; Trotta, Laura; Schumacher, Helmut; Lomp, Hans-Juergen; Hoppner, Sebastiaan; Young, Steve & BUYSE, Marc (2022) Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring. In: Therapeutic innovation & regulatory science. | - |
crisitem.journal.issn | 2168-4790 | - |
crisitem.journal.eissn | 2168-4804 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s43441-021-00341-5.pdf | Published version | 603.45 kB | Adobe PDF | View/Open |
WEB OF SCIENCETM
Citations
4
checked on Apr 24, 2024
Page view(s)
48
checked on Sep 7, 2022
Download(s)
10
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.